Reports – Pfizer
Report 76 – Pfizer Had Data to Announce Its COVID-19 Vaccine’s Alleged “Efficacy” in October 2020. Why Did Pfizer Delay the Announcement Until November 9, 2020, Six Days After the 2020 U.S. Presidential Election?
Executive summary On July 21, 2020, the United States (U.S.) government, Pfizer, and BioNTech signed a contract, known as a Statement of Work (SOW), for the rapid development of and obtaining regulatory licensure for a COVID-19 vaccine by October 31, 2020, a few days prior to the November 3, 2020, …
Report 63 – In Q3 2022, Pfizer Wrote Off $450 Million of Expired or Expiring COVID-19-Related Inventory.
Despite generating over $100 billion in revenue in 2022, Pfizer’s stock has dropped precipitously. Pfizer’s revenue was relatively flat, hovering between $41 billion and $51 billion, from 2014 to 2020. Then, its mRNA COVID-19 “vaccine” was awarded Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA) on December …
Report 59: The Flawed Trial of Pfizer’s COVID-19 mRNA “Vaccine.” 90% of Original Placebo Group Received at Least One mRNA Injection by March 2021
The clinical trial of Pfizer’s mRNA “vaccine” did not prove the mRNA injection is safe and effective, despite Pfizer’s claims to the contrary. In fact, Pfizer stopped collecting useful data long before the planned end date of the clinical trial. Based on an inaccurate diagnostic test confirming COVID-19 in a …
Report 87 – In Early 2021, Pfizer Documented Significant Harms and Deaths Following Vaccination with Its mRNA COVID Vaccine. The FDA Did Not Inform the Public
Introduction “5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162b2) Received Through 28-Feb-2021,” Pfizer’s post-marketing report, a required U.S. Food and Drug Administration (FDA) compliance document, is one of the ways in which the FDA assessed patients’ risks associated with Pfizer’s COVID-19 vaccine, BNT162b2. The data within the …
Internal Report 34: “100s of Possible Vaccine-Associated Enhanced Disease (VAED) Cases in First 3 Months of Pfizer’s mRNA COVID Vaccine Rollout, Yet Public Health Spokespeople Minimized Their Severity by Calling Them ‘Breakthrough Cases.’”
By late February 2021, a group of experts called Brighton Collaboration released a paper, which was published in Vaccine, clearly defining Vaccine-Associated Enhanced Disease (VAED), which is a more severe clinical presentation of a disease in a person vaccinated against that disease than would normally be seen in an unvaccinated …
Report 91 – FDA Based Moderna’s mRNA COVID Vaccine Approval on Test of a Completely Different Non-COVID Vaccine. Only Males Included in Test.
Moderna researchers did not test their COVID-19 mRNA drug, called SPIKEVAX, to find out where it would go in our bodies (biodistribution). Instead, their biodistribution study was for a completely different vaccine. Despite this substitution of one drug study for another, the U.S. Food and Drug Administration (FDA) approved SPIKEVAX …
Internal Report 32: “Pfizer’s ‘Post-Marketing Surveillance’ Shows mRNA-Vaccinated Suffered 1000s of COVID Cases in 1st 90 Days of Vaccine Rollout. Most Infections in the Vaccinated Categorized as ‘Serious Adverse Events.’”
Though spokespeople assured us that the COVID-19 injection stops—well—COVID, Pfizer and the Food and Drug Administration (FDA) both knew that during the first three months of Pfizer’s mRNA COVID-19 vaccine rollout, thousands of COVID cases were reported to Pfizer—among vaccinated people. The ‘COVID-19 Adverse Events of Special Interest’ (AESI) category …
Report 89 – WarRoom/DailyClout Researchers Find Pfizer Delayed Recording Vaccinated Deaths at Critical Juncture of EUA Process. Improper Delays in Reporting Deaths in the Vaccinated Led FDA to Misstate Vaccine’s Effectiveness, Influenced EUA Grant Decision
On September 5, 2023, DailyClout reported that a WarRoom/DailyClout Research Team—Corinne Michels, PhD; Daniel Perrier; Jeyanthi Kunadhasan, MD; Ed Clark, MSE; Joseph Gehrett, MD; Barbara Gehrett, MD; Kim Kwiatek, MD; Sarah Adams; Robert Chandler, MD; Leah Stagno; Tony Damian; Erika Delph; and Chris Flowers, MD—broke a huge story about there …
Internal Report 30: “2.5 Months After COVID Vaccine Rollout, Pfizer Changed Criteria for ‘Vaccination Failure,’ Causing 99% of Reported Cases to Not Meet That Definition. 3.9% of Reported ‘Lack of Efficacy’ Cases Ended in Death in First 90 Days of Public Vaccine Availability.”
The WarRoom/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1)—Barbara Gehrett, MD; Joseph Gehrett, MD; Chris Flowers, MD; and Loree Britt—penned a telling analysis of the “Vaccine Effectiveness” Safety Concern section found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-FEB-2021 (a.k.a., …
Report 86 – Pfizer’s Clinical Trial ‘Process 2’ COVID Vaccine Recipients Suffered 2.4X the Adverse Events of Placebo Recipients; ‘Process 2’ Vials Were Contaminated with DNA Plasmids.
Process 2 was hidden all along in Pfizer’s COVID “vaccine” clinical trial, and the WarRoom/DailyClout investigators’ findings about it are mind-blowing. The Food and Drug Administration (FDA) knew that the Process 2 subjects had very high levels of adverse events, but there is no evidence that the agency acted on …
Report 85: “The Underlying Pathology of Spike Protein Biodistribution in People That Died Post COVID-19 Vaccination”
The Scientific and Medical Advisory Committee hosted a meeting with special guest speaker Professor Arne Burkhardt. *A transcript was produced then edited with a diligent effort to leave the meaning unchanged. My additions are in italics. Professor Burkhardt was a German pathologist and researcher. He presented the findings of the …
Internal Report 26: “WarRoom/DailyClout Research Team Breaks Huge Story: More Cardiovascular Deaths in Vaxxed Than Unvaxxed; Pfizer Did Not Report Adverse Event Signal; Death Reporting Delays Favored Pfizer/Vaccinated.”
WarRoom/DailyClout Pfizer Documents Analysis team members Corinne Michels, PhD; Daniel Perrier; Jeyanthi Kunadhasan, MD; Ed Clark, MSE; Joseph Gehrett, MD; Barbara Gehrett, MD; Kim Kwiatek, MD; Sarah Adams; Robert Chandler, MD; Leah Stagno; Tony Damian; Erika Delph; and Chris Flowers, MD have published a bombshell study titled, “Forensic Analysis of …
Internal Report 25: “23% of Vaccinated Mothers’ Fetuses or Neonates Died. Suppressed Lactation and Breast Milk Discoloration Reported.”
The WarRoom/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1)—Barbara Gehrett, MD; Joseph Gehrett, MD; Chris Flowers, MD; and Loree Britt—wrote a shocking analysis of the “Use in Pregnancy and Lactation” section found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-FEB-2021 …
Report 80 – Moderna mRNA COVID-19 Injection Damaged Mammals’ Reproduction: 22% Fewer Pregnancies; Skeletal Malformations, Pain, Nursing Problems in Pups. FDA Knew, Yet Granted EUA
Based on “A GLP intramuscular combined developmental and perinatal/postnatal reproductive toxicity study of mRNA-1273 in rats. FDA-CBER-2–22-4207–0015,” Moderna’s COVID-19 mRNA drug damaged the reproductive systems of female rats their estrous cycles (the recurring period of sexual receptivity and fertility in many female mammals) were disturbed, they were less likely to …
Report 79 – mRNA COVID Vaccine-Induced Myocarditis at One Year Post-Injection: Spike Protein, Inflammation Still Present in Heart Tissue.
In spite of widespread censorship, the truth is coming out that myocarditis arising after injection with mRNA COVID “vaccines” is not rare, temporary, or mild. (https://openvaers.com/covid-data/myo-pericarditis) Statement 1: Myocarditis after COVID-19 “vaccine” injection is rare. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/myocarditis.html) [IMAGE 1 — ORIGINAL SOURCE PAGE 290] The Centers for Disease Control and Prevention’s …
Internal Report 22: “Thirty-Two Percent of Pfizer’s Post-Marketing Respiratory Adverse Event Patients Died, Yet Pfizer Found No New Safety Signals.”
The WarRoom/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1)—Joseph Gehrett, MD; Barbara Gehrett, MD; Chris Flowers, MD; and Loree Britt—wrote a compelling analysis of Respiratory Adverse Events of Special Interest (AESIs) found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-FEB-2021 …
Internal Report 21: “Women Suffered 94% of Dermatological Adverse Events Reported in First 90 Days of Pfizer COVID “Vaccine” Rollout. 80% of These Adverse Events Were Categorized As ‘Serious.’”
The WarRoom/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1)—Barbara Gehrett, MD; Joseph Gehrett, MD; Chris Flowers, MD; and Loree Britt—produced a report about Dermatological Adverse Events of Special Interest (AESIs) found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-FEB-2021 (a.k.a., …
Internal Report 1: “Liver Adverse Events—Five Deaths Within 20 Days of Pfizer’s mRNA COVID Injection. 50% of Adverse Events Occurred Within Three Days.”
The WarRoom/DailyClout Pfizer Analysis Post-Marketing Group—Team 1 created the following Liver (i.e., Hepatic) System Organ Class (SOC) Review from data in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-FEB-2021 (a.k.a., “5.3.6”). (https://www.phmpt.org/wp-content/uploads/2022/04/reissue_5.3.6-postmarketing-experience.pdf) There were 70 patient cases with 94 adverse events reported …
Report 52: “Nine Months Post-COVID mRNA ‘Vaccine’ Rollout, Substantial Birth Rate Drops in 13 European Countries, England/Wales, Australia, and Taiwan.”
Robert W. Chandler, MD, completed extensive research to write the article below. Some of the highlights of this important piece include: Nine months following the rollout of the COVID-19 mRNA “vaccines,” substantial birth rate drops were seen in 13 of 19 European countries, England and Wales (one entity based on …
Internal Report 3: “77% of Cardiovascular Adverse Events from Pfizer’s mRNA COVID Shot Occurred in Women, as Well as in People Under Age 65. Two Minors Suffered Cardiac Events.”
The WarRoom/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1) produced a shocking review of the Cardiovascular System Organ Class (SOC) from data in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-FEB-2021 (a.k.a., “5.3.6 ”). (https://www.phmpt.org/wp-content/uploads/2022/04/reissue_5.3.6-post-marketing-experience.pdf) 1,403 patients, or 3.3% of the …